Ticker Details
PMV Pharmaceuticals, Inc.
IPO Date:	September 25, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$70.93M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.44 | 3.39%
Avg Daily Range (30 D):	$0.05 | 3.56%
Avg Daily Range (90 D):	$0.04 | 3.01%

Institutional Daily Volume
Avg Daily Volume:	.42M
Avg Daily Volume (30 D):	.75M
Avg Daily Volume (90 D):	.41M

Trade Size
Avg Trade Size (Sh.):	107
Avg Trade Size (Sh.) (30 D):	286
Avg Trade Size (Sh.) (90 D):	264

Institutional Trades
Total Institutional Trades:	875
Avg Institutional Trade:	$2.33M
Avg Institutional Trade (30 D):	$4.46M
Avg Institutional Trade (90 D):	$4.46M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.22M
Avg Closing Trade (30 D):	$6.87M
Avg Closing Trade (90 D):	$6.87M
Avg Closing Volume:	147.98K

News

Mar 6, 2026 @ 1:00 PM PMV Pharmaceuticals Reports Full Year 2025 Financi... Source: Pmv Pharmaceuticals, Inc.

Jun 3, 2024 @ 1:55 PM Here's Why PMV Pharmaceuticals (PMVP) Could be Gre... Source: Zacks Equity Research

May 29, 2024 @ 11:00 AM Foundation Medicine and PMV Pharma Announce Collab... Source: PMV Pharmaceuticals, Inc.

May 28, 2024 @ 1:47 PM Here's Why You Should Buy Acrivon Therapeutics (AC... Source: Zacks Equity Research

Mar 18, 2024 @ 8:01 PM PMV Pharmaceuticals PYNNACLE Phase I Data of Rezat... Source: PMV Pharmaceuticals, Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.48	$-.34	$-1.48
Diluted EPS	$-1.48	$-.34	$-1.48
Revenue	$6.34M	$1.23M	$6.34M
Gross Profit
Net Income / Loss	$-77.74M	$-18.04M	$-77.74M
Operating Income / Loss	$-86.21M	$-19.24M	$-86.21M
Cost of Revenue
Net Cash Flow	$-2.9M	$1.65M	$-2.9M
PE Ratio